Phase II induction therapy with docetaxel and carboplatin in NSCLC llIAAIlB: FDG-PET response predicts overall and disease free survival.

ISSN
1527-7755
0732-183X
Date Issued
2005
Author(s)
Griesinger, Frank
Dorge, H.
Schmidberger, Heinz
Keppler, U.
Schirren, J.
Baum, R. P.